Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Roos‐Weil, Damien"'
Autor:
Nguyen-Khac F; Unité de Cytogénétique, Hôpital Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, France.; Cell Death and Drug Resistance in Lymphoproliferative Disorders Team, Centre de Recherche Des Cordeliers, INSERM, Sorbonne Université, Université Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Paris, France., Baron M; Service d'Hématologie Clinique, Hôpital Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, France., Guièze R; Hematology Department, Clermont-Ferrand University Hospital, Clermont Auvergne University, Clermont-Ferrand, France., Feugier P; Department of Hematology, University Hospital of Nancy, Nancy, France., Fayault A; FILO, Tours University Hospital, Tours, France., Raynaud S; Laboratory of Hematology, University Hospital of Nice, Nice, France., Troussard X; Laboratory of Hematology, CHU Caen Normandie, Caen, France., Droin N; Inserm U1287, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Damm F; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin, Germany., Smagghe L; Unité de Cytogénétique, Hôpital Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, France., Susin S; Cell Death and Drug Resistance in Lymphoproliferative Disorders Team, Centre de Recherche Des Cordeliers, INSERM, Sorbonne Université, Université Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Paris, France., Leblond V; Service d'Hématologie Clinique, Hôpital Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, France., Dartigeas C; Department of Hematology, CHU Tours, Hôpital Bretonneau, Tours, France., Van den Neste E; Department of Hematology, Cliniques Universitaires Université Catholique de Louvain Saint-Luc, Bruxelles, Belgium., Leprêtre S; Department of Clinical Hematology, Centre Henri Becquerel, Rouen, France., Bernard OA; Inserm U1170, Université Paris-Saclay, Gustave Roussy Cancer Campus, Villejuif, France., Roos-Weil D; Cell Death and Drug Resistance in Lymphoproliferative Disorders Team, Centre de Recherche Des Cordeliers, INSERM, Sorbonne Université, Université Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Paris, France.; Service d'Hématologie Clinique, Hôpital Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, France.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Aug; Vol. 205 (2), pp. 495-502. Date of Electronic Publication: 2024 Apr 23.
Autor:
Krzisch D; Sorbonne Université, Hôpital Pitié-Salpêtrière, APHP, Paris, France.; Centre de Recherche des Cordeliers, INSERM, Cell Death and Drug Resistance in Lymphoproliferative Disorders Team, Sorbonne Université, Université Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Paris, France., Guedes N; Sorbonne Université, Hôpital Pitié-Salpêtrière, APHP, Paris, France., Boccon-Gibod C; Sorbonne Université, Hôpital Pitié-Salpêtrière, APHP, Paris, France., Baron M; Sorbonne Université, Hôpital Pitié-Salpêtrière, APHP, Paris, France., Bravetti C; Sorbonne Université, Biologie moléculaire, Hôpital Pitié-Salpêtrière, APHP, Paris, France., Davi F; Sorbonne Université, Biologie moléculaire, Hôpital Pitié-Salpêtrière, APHP, Paris, France., Armand M; Sorbonne Université, Biologie moléculaire, Hôpital Pitié-Salpêtrière, APHP, Paris, France., Smagghe L; Sorbonne Université, Unité de Cytogénétique, Hôpital Pitié-Salpêtrière, APHP, Paris, France., Caron J; Centre de Recherche des Cordeliers, INSERM, Cell Death and Drug Resistance in Lymphoproliferative Disorders Team, Sorbonne Université, Université Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Paris, France., Bernard OA; Université Paris-Saclay, Gustave Roussy, INSERM, Villejuif, France., Susin S; Centre de Recherche des Cordeliers, INSERM, Cell Death and Drug Resistance in Lymphoproliferative Disorders Team, Sorbonne Université, Université Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Paris, France., Chapiro E; Centre de Recherche des Cordeliers, INSERM, Cell Death and Drug Resistance in Lymphoproliferative Disorders Team, Sorbonne Université, Université Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Paris, France.; Sorbonne Université, Unité de Cytogénétique, Hôpital Pitié-Salpêtrière, APHP, Paris, France., Leblond V; Sorbonne Université, Hôpital Pitié-Salpêtrière, APHP, Paris, France., Nguyen-Khac F; Centre de Recherche des Cordeliers, INSERM, Cell Death and Drug Resistance in Lymphoproliferative Disorders Team, Sorbonne Université, Université Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Paris, France.; Sorbonne Université, Unité de Cytogénétique, Hôpital Pitié-Salpêtrière, APHP, Paris, France., Roos-Weil D; Sorbonne Université, Hôpital Pitié-Salpêtrière, APHP, Paris, France.; Centre de Recherche des Cordeliers, INSERM, Cell Death and Drug Resistance in Lymphoproliferative Disorders Team, Sorbonne Université, Université Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Paris, France.
Publikováno v:
American journal of hematology [Am J Hematol] 2021 Dec 01; Vol. 96 (12), pp. 1569-1579. Date of Electronic Publication: 2021 Sep 27.
Autor:
Moulin C; Department of Hematology, University Hospital of Nancy, Nancy, France.; Inserm, CHRU, University of Lorraine, CIC Clinical Epidemiology, Nancy, France., Guillemin F; Inserm, CHRU, University of Lorraine, CIC Clinical Epidemiology, Nancy, France., Remen T; Methodology, Data Management and Statistic Unit, MPI Department, University Hospital of Nancy, Nancy, France., Bouclet F; Hematology Department, Clermont-Ferrand University Hospital, Clermont Auvergne University, Clermont-Ferrand, France., Hergalant S; Inserm UMRS1256 Nutrition-Génétique et Exposition aux Risque Environnementaux (N-GERE), University of Lorraine, Nancy, France., Quinquenel A; University Hospital of Reims, Hôpital Robert Debré, Reims Champagne-Ardenne University, Unité de Formation et de Recherche (UFR) Médecine, Reims, France., Dartigeas C; Haematology Division, University Hospital of Tours, Tours, France., Tausch E; Department of Internal Medicine III, Ulm University, Ulm, Germany., Lazarian G; Laboratoire d'hématologie, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Paris, France., Blanchet O; Biological Resource Center of Angers, University Hospital of Angers, Angers, France., Lomazzi S; Biological Resource Center of Nancy, Nancy, France., Chapiro E; Hematology Department, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France., Schneider C; Department of Internal Medicine III, Ulm University, Ulm, Germany., Nguyen-Khac F; Hematology Department, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France., Davi F; Hematology Department, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France., Hunault M; Department of Hematology, University Hospital of Angers, Angers, France., Tomowiak C; Department of Hematology, CHU Poitiers, Poitiers, France.; CIC1402 Inserm Poitiers, Poitiers, France., Roos-Weil D; Department of Hematology, Hôpital de la Pitié-Salpêtrière, APHP, Paris, France., Siebert R; Institute of Human Genetics, Ulm University & Ulm University Medical Center, Ulm, Germany., Thieblemont C; Department of Hematology, Hôpital Saint-Louis, Paris, France., Cymbalista F; Laboratoire d'hématologie, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Paris, France., Laribi K; Department of Hematology, Centre Hospitalier Le Mans, Le Mans, France., Béné MC; Service d'Hématologie Biologique, Pôle Laboratoires, CHU de Nantes, Nantes, France., Stilgenbauer S; Department of Internal Medicine III, Ulm University, Ulm, Germany., Guièze R; Hematology Department, Clermont-Ferrand University Hospital, Clermont Auvergne University, Clermont-Ferrand, France., Feugier P; Department of Hematology, University Hospital of Nancy, Nancy, France.; Inserm UMRS1256 Nutrition-Génétique et Exposition aux Risque Environnementaux (N-GERE), University of Lorraine, Nancy, France., Broséus J; Inserm UMRS1256 Nutrition-Génétique et Exposition aux Risque Environnementaux (N-GERE), University of Lorraine, Nancy, France.; Université de Lorraine, CHRU-Nancy, service d'hématologie biologique, pôle laboratoires, Nancy, France.
Publikováno v:
American journal of hematology [Am J Hematol] 2021 Sep 01; Vol. 96 (9), pp. E311-E314. Date of Electronic Publication: 2021 Jun 02.
Autor:
Bühler MM; Department of Pathology and Molecular Pathology, University Hospital and University of Zurich, Zurich, Switzerland; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Hematopathology Section, Laboratory of Pathology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain., Lu J; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany., Scheinost S; Molecular Therapy in Hematology and Oncology, National Center for Tumor Diseases, German Cancer Research Center (DKFZ), Heidelberg, Germany., Nadeu F; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Cancer (CIBERONC), Madrid, Spain., Roos-Weil D; Gustave Roussy, INSERM U1170, Villejuif and Université Paris-Saclay Orsay, France., Hensel M; Mannheim Oncology Practice, Mannheim, Germany., Thavayogarajah T; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland., Moch H; Department of Pathology and Molecular Pathology, University Hospital and University of Zurich, Zurich, Switzerland., Manz MG; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland., Haralambieva E; Department of Pathology and Molecular Pathology, University Hospital and University of Zurich, Zurich, Switzerland., Marques Maggio E; Department of Pathology and Molecular Pathology, University Hospital and University of Zurich, Zurich, Switzerland., Beà S; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Hematopathology Section, Laboratory of Pathology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cancer (CIBERONC), Madrid, Spain., Giné E; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Cancer (CIBERONC), Madrid, Spain; Department of Hematology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain., Campo E; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Hematopathology Section, Laboratory of Pathology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cancer (CIBERONC), Madrid, Spain., Bernard OA; Gustave Roussy, INSERM U1170, Villejuif and Université Paris-Saclay Orsay, France., Huber W; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany., Zenz T; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland. Electronic address: thorsten.zenz@usz.ch.
Publikováno v:
Leukemia research [Leuk Res] 2021 Aug; Vol. 107, pp. 106608. Date of Electronic Publication: 2021 May 03.
Autor:
Roos-Weil D; Institut National De La Santé Et De La Recherche Médicale (INSERM) U1170, Villejuif, France.; Gustave Roussy, Villejuif, France.; Université Paris Saclay, France.; Equipe Labellisée Ligue Nationale Contre Le Cancer., Nguyen-Khac F; INSERM U1138, Paris, France.; Université Pierre Et Marie Curie-Paris 6, France.; Service D'hématologie Biologique, Hôpital Pitié-Salpêtrière, APHP, Paris, France., Bernard OA; Institut National De La Santé Et De La Recherche Médicale (INSERM) U1170, Villejuif, France.; Gustave Roussy, Villejuif, France.; Université Paris Saclay, France.; Equipe Labellisée Ligue Nationale Contre Le Cancer.
Publikováno v:
American journal of hematology [Am J Hematol] 2016 May; Vol. 91 (5), pp. 518-28. Date of Electronic Publication: 2016 Apr 04.
Autor:
Kostopoulou, Fotini, Gabillaud, Clementine, Chapiro, Elise, Grange, Beatrice, Tran, Julie, Bouzy, Simon, Degaud, Michael, Ghamlouch, Hussein, Le Garff‐Tavernier, Magali, Maloum, Karim, Choquet, Sylvain, Leblond, Veronique, Gabarre, Jean, Lavaud, Anne, Morel, Veronique, Roos‐Weil, Damien, Uzunov, Madalina, Guieze, Romain, Bernard, Olivier A., Susin, Santos A., Tournilhac, Olivier, Nguyen‐Khac, Florence
Publikováno v:
Cancer Medicine
Cancer Medicine, 2019, 8 (6), pp.3131-3141. ⟨10.1002/cam4.2123⟩
Cancer Medicine, Wiley, 2019, 8 (6), pp.3131-3141. ⟨10.1002/cam4.2123⟩
Cancer Medicine, 2019, 8 (6), pp.3131-3141. ⟨10.1002/cam4.2123⟩
Cancer Medicine, Wiley, 2019, 8 (6), pp.3131-3141. ⟨10.1002/cam4.2123⟩
International audience; The different types of drug resistance encountered in chronic lymphocytic leukemia (CLL) cannot be fully accounted for by the 17p deletion (and/or TP53 mutation), a complex karyotype (CK), immunoglobulin heavy-chain variable r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d039563828876de07a02708a4ba46242
https://hal.sorbonne-universite.fr/hal-02273234/document
https://hal.sorbonne-universite.fr/hal-02273234/document